Company profile: Vibalogics
1.1 - Company Overview
Company description
- Provider of contract development and manufacturing services for live biological products, including process development, manufacturing and fill & finish for oncolytic viruses, gene therapies and vaccines. Capabilities span viral vector and live virus production, RNA and LNP manufacturing, plasmid development and manufacturing, upstream/downstream and formulation development, and cGMP manufacturing for phase 1–2 clinical trials.
Products and services
- Viral Vector & Live Virus Manufacturing: cGMP-compliant virotherapy programs encompassing plasmid production, analytical and process development, and manufacturing for oncolytic viruses, viral vector vaccines, and gene therapies
- RNA Technology: end-to-end RNA development and manufacturing services covering plasmid production, RNA production, and lipid nanoparticle (LNP) fabrication to support biopharma programs
- Fill and Finish Biologics: integrated operations enabling various vial and syringe formats via automated and manual filling, alongside decontamination and particle counting systems for final biologics
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Vibalogics
Avid Bioservices
HQ: United States
Website
- Description: Provider of end-to-end biologics services, including mammalian protein process development, drug substance development, CGMP manufacturing from early stages to commercial scale, and analytical services; also specializes in viral vector design, optimization, and scalable production for gene therapy and vaccine applications. Expansion doubles capacity to service a $40m backlog and support owner Peregrine.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Avid Bioservices company profile →
Parexel
HQ: United States
Website
- Description: Provider of biopharmaceutical services, including clinical research, medical communications, consulting, commercialization, and advanced technology for pharmaceutical, biotechnology, and medical device industries. Offerings include clinical trial management, RWE and late phase research, market access strategy, regulatory compliance and pharmacovigilance, and advanced analytics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Parexel company profile →
Acsel Health
HQ: United States
Website
- Description: Provider of consulting services for the life sciences industry, ensuring patient access to life-saving medicines and helping life-changing innovations and health technologies reach their full potential through critical stages from early development to market maturity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Acsel Health company profile →
Marvel Biotechnology
HQ: Canada
Website
- Description: Provider of biotech discovery and development of synthetic derivatives of proven drugs, including MB-204, a fluorinated derivative of istradefylline, for neurological diseases (depression, anxiety, Alzheimer's, ADHD), liver fibrosis due to NASH, and adjunctive cancer therapies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Marvel Biotechnology company profile →
Synchrogenix
HQ: United States
Website
- Description: Provider of strategic regulatory writing and related services for the pharmaceutical and biotech industry, offering regulatory strategy, consulting, and submissions support from preclinical to post-marketing; eCTD publishing and management; medical writing and scientific communications; clinical data transparency, anonymization and redaction; document quality and management; and GlobalSubmit eCTD software.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Synchrogenix company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Vibalogics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Vibalogics
2.2 - Growth funds investing in similar companies to Vibalogics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Vibalogics
4.2 - Public trading comparable groups for Vibalogics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →